Jan 17, 2017 Letter to OWCP Shareholders http://finance.yahoo.com/news/owc-pharmaceutical-research-corp-issues-121500795.html OWCP's Action Items for 2017: During the second quarter of 2017 OWCP intends to initiate its U.S marketing program for its Psoriasis Topical Cream. At the same time, we intend to begin investigating the applicability of topical cream for other skin conditions and disorders.
OWCP intends to proceed with the advancement of our cannabis-based treatment for multiple myeloma, with the objective of proceeding with additional studies.
OWCP intends to evaluate the launch of one or more studies to determine the applicability of cannabinoid-based pharmaceuticals for other medical conditions and disorders, such as fibromyalgia and migraines.
Why am I so confident in OWCP? Here are 16 reasons from 2016!
- #16.Though it didn’t take place in 2016, it’s still huge. TEVA, a 115 year old pharmaceutical company with over $20B in revenue, made an offer to purchase OWCP’s patents! This leads me to believe there will be future offers as OWCP continues to
advance their research and get closer to shipping products worldwide!
OWCP: Market Potential of Upcoming Products
So, as I’ve pointed out – a handful of Cannabis/Marijuana companies with billions of Outstanding Shares, generating little or no revenue, posting annual losses, and who are still being financed with (Toxic) Convertible Notes achieving a Market Value of $115M all the way to $424M (for a company with $2.1M revenue, but still with billions of shares)… Why on God’s green Earth would OWCP not climb to dollars per share? (Note: $2/share is a $280M Market Value)
OWCP: Annual Letter to Shareholders
I’ve pointed out in our Year End Recap that Jeffrey Friedland is a huge asset. Quite frankly, I’m a fan of Mr. Friedland. He’s all over the Medical Marijuana industry events.
Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, VersloZinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbe
OWCP: Recent TEVA Pharma Buyouts
Here’s how I came up with my $500M valuation (which, is quite possibly very conservative):
- OWCP has NO TOXIC Debt
That was announced in an 8-K back in October. (This isn’t some OTC Pink Sheet operation.) They have real investors. That same October 8-K talks about a $300,000 non-interest bearing loan. They have royalty-based distribution deals with MedMar and Michepro, because the distributor obviously has confidence too.
I would recommend to my friends, do some DD and look up what OWCP may be working on with their Patent for Nasal Spray
Cannabis Nasal Spray can stop seizures in their tracks,
these sprays can also be used for Parkinson Disease
and pain from Cancers
Also Cannabis Nasal Sprays can help with Brain Cancer
(for people who have trouble swallowing these sprays really help)
Cannabis nasal spray stop grand mal seizure in children
BIG MONEY !
FULL ARTICLE READ THIS!